Brazil establishes blood-service standards:
This article was originally published in Clinica
Brazil's haemotherapy services are subject to new accreditation, service and facility standards, following the publication of an official manual to support a national quality-assurance drive. The initiative of the Brazilian health surveillance agency (Anvisa), the national accreditation organisation (ONA) and the national haematology and haemotherapy society (SBHH), was launched in May 1998. It has met the national target to establish a quality-assurance framework in 2003.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.